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CLINICAL SCIENCE
Long-Term Follow-up of Intrastromal Corneal Ring
Segment Implantation in Pediatric Keratoconus
José F. Alfonso, MD, PhD,* Luis Fernández-Vega-Cueto, MD, PhD,* Carlos Lisa, MD, PhD,*
Tiago Monteiro, MD,† and David Madrid-Costa, PhD‡
Purpose: To evaluate efficacy, safety, and stability of Ferrara-type
intrastromal corneal ring segment (ICRS) implantation for visual
rehabilitation in pediatric patients with keratoconus.
Methods: This study included patients with keratoconus aged 18
years or younger who had received Ferrara-type ICRS implantation.
The uncorrected and corrected distance visual acuities, residual
refractive errors, and root mean square for coma-like aberration were
recorded preoperatively and at 6 months, 1, 3, and 5
years postoperatively.
Results: One hundred eighteen eyes of 88 patients (mean age 16.1
6 1.89; range 10–18) were studied. All patients were examined at
a 6-month follow-up after ICRS implantation, and at the 12-, 36-,
and 60-month follow-ups, 97, 71, and 23 eyes were evaluated,
respectively. Mean uncorrected distance visual acuity (logarithm
of minimum angle of resolution) changed from 0.67 6 0.37
preoperatively to 0.37 6 0.30, 6 months after ICRS implantation
(P , 0.0001). Mean corrected distance visual acuity increased in
turn from 0.19 6 0.15 to 0.10 6 0.12 (P , 0.0001). The percentage
of eyes with a refractive cylinder #2.00 D increased from 30.5%
before surgery to 70.3% 6 months later, and the root mean square for
corneal coma-like aberration showed a statistically significant
decrease (P , 0.001). At the follow-up visits, refractive and visual
values remained stable compared with those of the 6-month visit.
Conclusions: Our long-term results suggest that Ferrara-type ICRS
implantation is a safe, effective, and stable procedure for restoring
vision in pediatric patients with keratoconus.
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Keratoconus is a disorder of the cornea that producesabnormalities, such as high regular and irregular astig-
matism and increased higher-order aberrations, with adverse
effects on visual quality in the patients concerned.1,2 The
impact of this corneal disease depends on its severity; the
more advanced the stage of keratoconus, the greater
the decline in visual quality. Considering that keratoconus
in the pediatric population is usually more severe and
progresses faster than in adults,3–5 it is clear that, in this
group, it is crucial to address 2 challenges, namely to slow
down progression and to minimize the impact of the disease
on the visual quality of the patient.
Regarding disease stabilization, in light of the results
published, it appears that cross-linking (CXL) is effective in
slowing down progression in the pediatric population,6–8
although some patients (around 20%8) might require retreat-
ment. An important question to consider is whether this
procedure should be carried out in all cases of pediatric
keratoconus. Some authors have suggested initiating this
treatment as soon as the diagnosis is confirmed,5 whereas
a recent study9 concluded that there is no urgency in treating
these patients where there is no proof of progression.
Beyond keratoconus stabilization, the other important
challenge is to improve visual quality. Intrastromal corneal
ring segment (ICRS) implantation has proven to be sound and
efficacious in mitigating corneal abnormalities and improving
visual quality in adult patients with this disease,10–12 but few
studies have dealt with this procedure for visual rehabilitation
in children.13,14 A recent study13 has evaluated the safety and
visual results of ICRS implantation, followed by CXL in child
keratoconus, and the findings suggest that ICRS implantation
is safe and effective for visual rehabilitation in this segment of
the population. Given the aforementioned discrepancy regard-
ing the best moment for CXL treatment in the pediatric
population, and whether CXL should be used to treat all
cases,5,9 2 questions arise concerning the management of
these patients, namely, whether CXL treatment is needed after
ICRS implantation in all cases, and whether the efficacy
outcome of ICRS implantation previously reported13 would
have been less positive in a long-term follow-up if treatment
with CXL had not been applied.
In the current study, we present the 5-year, long-term
visual and refractive results of ICRS implantation in a large
sample of pediatric keratoconus patients.
PATIENTS AND METHODS
This study was a longitudinal retrospective analysis of the
long-term results of Ferrara-type ICRS implantation (AJL
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Ophthalmic, Spain) in keratoconus patients aged 18 years or
younger and was carried out at the Fernández-Vega Ophthalmo-
logical Institute in Oviedo, Spain. The tenets of the Declaration of
Helsinki were followed and full ethical approval from the
Institute was obtained. After receiving a full description of the
nature of the study and possible consequences of surgery, all
patients provided informed consent.
Inclusion criteria were pediatric patients diagnosed with
keratoconus, contact lens intolerance, and a clear cornea, along
with a minimum corneal thickness of over 400 mm at the optical
zone involved in the implantation (a general criterion for
surgery). Diagnosis of keratoconus was established by the
combination of computerized videokeratography of the anterior
and posterior corneal surfaces (Sirius, CSO, Italy), K readings,
and corneal pachymetry.15–17 Grading of keratoconus was based
on Amsler-Krumeich classification. The exclusion criteria
defined for the study were patients who had keratoconus stage
IV (according to Amsler-Krumeich classification), previous
corneal or intraocular surgery, a history of herpetic keratitis,
and a diagnosed autoimmune disease or a systemic connective
tissue disease.
A complete ophthalmologic examination was performed
on all patients before surgery, including uncorrected (UDVA)
and best-corrected (CDVA) distance visual acuity, manifest and
cycloplegic refractions, keratometry, corneal topography (Sir-
ius), anterior segment optical coherence tomography (Visante
Zeiss-Meditec, Germany), endothelial cell count, ultrasonic
pachymetry, slit-lamp microscopy, Goldmann applanation
tonometry, and binocular indirect ophthalmoscopy. Contact lens
use was discontinued 1 month before corneal topography.
All eyes in this study received Ferrara-type ICRS
(AJL Ophthalmic) implants, which are made of polymethyl
methacrylate and with a triangular cross-section that
induces a prismatic effect on the cornea. The optical
diameter of the ICRS was 5.0 mm (AFR5) with a base of
0.6 mm, or 6.0 mm (AFR6) with a base of 0.8 mm,
available in variable thicknesses (0.15 mm to 0.30 mm,
increasing in 0.05 mm increments) and with arc lengths of
90, 120, 150, and 210 degrees. The ICRSs were implanted
following the nomogram used in previous studies.18–21
Two experienced surgeons performed all implantation
procedures (J.F.A., C.L.) using a femtosecond laser, and
using the procedure described in previous studies.18–21
Preoperative medication included proparacaine 0.5%, ci-
profloxacin 0.3%, and oxybuprocaine ClH 0.2%. The
postoperative treatment regimen was a combination of
antibiotic (tobramycin, 3 mg/mL) and steroid eye drops
(dexamethasone, 1 mg/mL) (Tobradex; Alcon Laborato-
ries, Inc, Fort Worth, TX) 3 times daily for 2 weeks, and
the dose was tapered off over the following 2 weeks.
Patients were scheduled for postoperative clinical
evaluation at 1 day, 1 week, 1, 3, and 6 months, 1 year,
and then every 2 years thereafter. The clinical measurements
taken primarily included manifest refraction, slit-lamp bio-
microscopy, UDVA and CDVA [measured on the logarithm
of minimum angle of resolution (logMAR)], corneal topog-
raphy, and corneal aberrometry. The root mean square (RMS)
for coma-like aberrations [computed for the Zernike terms Z
(3, 1) and Z (3, 21)] was evaluated for a pupil size of
4.5 mm. The manifest refraction was analyzed using the
power vector method proposed by Thibos and Horner.22
When compared with a previous visit, refractive
instability was defined as an increase of at least 1.5 D in
maximum keratometry (measured by Sirius) or an increase of
at least 1.5 D in the topographic cylinder and visual instability
as a decrease greater than 1 line of CDVA.
Data analysis was performed using SPSS for Win-
dows, version 14.0 (SPSS Inc, Chicago, IL). Normality was
checked with the Kolmogorov–Smirnov test, and
a repeated-measures analysis of variance and a Bonferroni
test were performed to compare the results. Differences
were considered to be statistically significant when the P
value was , 0.05. At each follow-up stage, only the
patients who attended that visit were included in the
statistical analysis.
RESULTS
The study included 118 eyes of 88 patients with a mean
age of 16.1 6 1.89 (range 10–18). ICRSs were successfully
implanted in all cases, with no intraoperative or postoperative
complications. Table 1 shows patient demographics and
preoperative characteristics. All patients were examined at
the 6-month follow-up, and Figure 1 shows the efficacy of the
ICRS implantation at that time. The mean UDVA (logMAR)
changed from 0.67 6 0.37 before ICRS implantation to 0.37
6 0.30, 6 months later (P , 0.0001). The mean CDVA, in
turn, increased from the preoperative 0.19 6 0.15 to a post-
operative 0.10 6 0.12 (P , 0.0001). The 6-month efficacy
index (mean postoperative UDVA/mean preoperative CDVA)
was 0.8%, and 74.5% of the eyes (88 eyes) showed a gain of
lines of CDVA (Fig. 2). The 6-month safety index (ratio of
postoperative to preoperative monocular CDVA) was 1.2.
Figure 3 shows the cumulative distribution of CDVA, before
surgery and 6 months later. The percentage of eyes with
a CDVA of 0.1 logMAR (about 20/25 or better) increased
from 39% to 73.7%, whereas the percentage of eyes with
a CDVA of 0.0 logMAR varied from 5.1% to 32.2%.
The spherical equivalent decreased from a preoperative
21.77 6 2.36 D to a postoperative value of 21.08 6 1.88 D
(P = 0.0005). The blur strength (B) value, in turn, dropped
TABLE 1. Patient Demographics
Characteristic Value
Eyes (n) 118
Age (yr) 16.1 6 1.89 (10 to 18)
Gender (Male/Female) (%) 80.5/19.5
Spherical equivalent (D) range 21.77 6 2.35 (+2.25 to 29.5)
Refractive cylinder (D) range 23.64 6 2.48 (0.00 to 211.50)
Minimum K (D) range 45.32 6 2.77 (40.75 to 55.00)
Maximum K (D) range 49.47 6 4.03 (43.50 to 58.00)
Mean central K (D) range 47.18 6 2.88 (42.25 to 55.00)
Comatic aberration (mm) range 1.56 6 0.89 (0.38 to 4.50)
Age, pre-ICRS implantation spherical equivalent, refractive cylinder, pre-keratom-
etry (K) readings and pre-comatic aberration (means 6 SD and range).
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from 3.00 6 2.14 D to 1.90 6 1.62 D (P , 0.0001). Figure 4
shows the refractive astigmatism power vector (J0 and J45)
before ICRS implantation and at 6 months. The percentage of
eyes with a refractive cylinder # 2.00 D increased from
30.5% to 70.3%, whereas the percentage of eyes with
a refractive cylinder #1.50 D varied from 20.3% to 61.0%.
The mean maximum K reading declined from a pre-implant
49.47 6 4.03 D to a post-implant value of 47.64 6 3.02 D
(,0.0001), whereas the mean minimum reading dipped from
45.32 6 2.77 D to 44.99 6 2.40 D (P = 0.03). The RMS for
corneal coma-like aberration for a 4.5-mm pupil changed
from 1.56 6 0.89 mm to 1.14 6 0.87 mm (P , 0.001).
FIGURE 1. UDVA and CDVA before
and 6 months after ICRS implanta-
tion (efficacy).
FIGURE 2. Change in CDVA 6
months after ICRS implantation
(safety).
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Visual and Refractive Stability: 12-
Month Follow-up
Seventy-four patients (97 eyes) attended the 6- and 12-
month follow-up visits. All visual acuity and refractive
parameters analyzed were stable over this period (Table 2).
During this postoperative period, only 1 eye had lost 2 lines
of CDVA. Two eyes had an increase of 1.75 D of topographic
cylinder and 3 eyes had an increase in maximum keratometry
higher than 1.5 D. In these 5 eyes, the CDVA values were
maintained between the 6- and 12-month visits.
Visual and Refractive Stability: 36-
Month Follow-up
Fifty-seven patients (71 eyes) completed the 6-, 12-,
and 36-month follow-up visits. All visual and refractive
FIGURE 3. Plot comparing the
cumulative CDVA before and 6
months after surgery.
FIGURE 4. Representation of the
astigmatic vector (J0 and J45) before
and 6 months after ICRS
implantation.
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parameters analyzed remained stable over this period (Table
3). Three eyes lost 2 lines of CDVA between the 12- and 36-
month visits. Five eyes showed an increase in maximum
keratometry higher than 1.5 D, and in 2 of these 5, this finding
was accompanied by a change in topographic cylinder higher
than 1.5 D, but none of them lost lines of CDVA.
Visual and Refractive Stability: 60-
Month Follow-up
Twenty-one patients (23 eyes) attended the 6-, 12-, 36-,
and 60-month follow-up visits. All visual and refractive
parameters assessed were stable over this period (Table 4).
Between the visit at 36 months and the final visit at 5 years,
none of these 18 eyes had lost 2 or more lines of CDVA, or
experienced an increase in maximum keratometry$ 1.5 D, or
a change in topographic cylinder $ 1.5 D.
DISCUSSION
Keratoconus in the pediatric population progresses
faster than in adults3–5 and is evidenced by visual deteriora-
tion. Hence, it is evident that, in child patients, it is
particularly important to improve visual performance as
promptly as possible to avoid significant deterioration, which
could have a negative impact on their quality of life.
Recently, Abdelmassih et al13 studied the safety and efficacy
of sequential ICRS implantation and CXL in treating
keratoconus in children. The authors concluded that this
combined procedure was safe and effective for visual
restoration in patients with this condition and poor CDVA.
An interesting question is whether CXL should be carried out
in all cases to maintain this positive outcome because there is
controversy regarding the right moment for CXL treatment in
children. We consider this an important matter because
although CXL is a safe and effective treatment in this
group,6,7 it should not be considered free of potential
complications.6 Some studies have suggested5 that CXL
should be performed as soon as possible, even before signs
of disease progression appear. However, a recent study9 that
compared the long-term outcomes of CXL treatment in
pediatric patients with the long-term findings of the fellow
untreated keratoconic eyes found that the untreated eyes did
not exhibit progression during a 5-year follow-up. The
authors concluded that it is not urgent to perform CXL
treatment in child patients without evidence of disease
progression. It would appear, as Perez-Straiozota et al7
commented in his review article about corneal CXL treatment
in this population, that the number of studies is limited and
“there is still no standardization for management in
pediatric patients.”
This current study evaluates the long-term visual and
refractive outcome of ICRS implantation alone for visual
rehabilitation in child patients. The results were recorded at 6
months, 1, 3, and 5 years. One hundred eighteen eyes were
examined at the 6-month follow-up, and all the visual and
refractive parameters analyzed improved significantly after
ICRS implantation. The mean UDVA (logMAR) changed
from 0.676 0.37 (about 20/100) before ICRS implantation to
0.37 6 0.30 (about 20/50) 6 months later. The percentage of
eyes with a CDVA of 0.1 logMAR (about 20/25 or better)
increased from 39% preoperatively to 73.7% postoperatively.
In turn, the percentage of eyes with a refractive cylinder #
1.50 D varied from 20.3% to 61%. Furthermore, the mean
maximum and minimum K reading and the RMS for corneal
coma-like aberration declined after implantation. Few pre-
vious studies have evaluated the results of ICRS implantation
alone in pediatric patients.14,23 Khan and Muhtaseb23 pre-
sented the case of an 11-year-old patient who underwent
bilateral implantation of Intacs SK ICRS (Addition Technol-
ogy, Inc, Lombard, IL) and who experienced a significant
improvement in UDVA, CDVA, and refractive error after
surgery. A recent study14 has analyzed the visual and
refractive results of Intacs/Intacs SK ICRS implantation in
14 child keratoconus patients. This study showed that ICRS
implantation effected a reduction in the keratometry readings
and an improvement in UDVA and CDVA. These encourag-
ing data suggest that ICRS implantation, both alone14,23 or in
combination with CXL,13 is an effective and safe procedure
for visual rehabilitation in pediatric patients, allowing them to
grow and develop and to exhibit better visual performance.
TABLE 2. Visual and Refractive Results at the 6- and 12-Month
Follow-up
Characteristic Value
Eyes (n) 97
Characteristic
6-Month
Follow-up
12-Month
Follow-up P Value
UDVA (logMAR) 0.38 6 0.29 0.37 6 0.27 0.35
CDVA (logMAR) 0.11 6 0.11 0.11 6 0.13 0.39
Mean spherical equivalent (D) 21.24 6 1.97 21.32 6 1.98 0.15
Mean refractive cylinder (D) 21.89 6 1.45 21.93 6 1.46 0.31
Mean minimum K (D) 45.06 6 2.30 45.12 6 2.24 0.27
Mean maximum K (D) 47.46 6 2.83 47.61 6 2.68 0.11
Comatic aberration (mm) 1.23 6 0.90 1.21 6 0.89 0.37
TABLE 3. Visual and Refractive Results at the 6-, 12-, and 36-
Month Follow-up
Characteristic Value
Eyes (n) 71
Characteristic
6-Month
Follow-up
12-Month
Follow-up
36-Month
Follow-up
P
Value
UDVA (logMAR) 0.41 6 0.30 0.39 6 0.27 0.39 6 0.25 0.21
CDVA (logMAR) 0.12 6 0.12 0.12 6 0.12 0.11 6 0.11 0.19
Mean spherical
equivalent (D)
21.35 6 1.92 21.38 6 1.96 21.42 6 1.87 0.29
Mean refractive
cylinder (D)
21.90 6 1.33 21.94 6 1.35 22.10 6 1.22 0.09
Mean minimum K
(D)
45.15 6 2.38 45.11 6 2.32 45.37 6 2.47 0.1
Mean maximum K
(D)
47.42 6 2.90 47.49 6 2.78 47.76 6 2.82 0.06
Comatic aberration
(mm)
1.29 6 1.01 1.26 6 1.00 1.17 6 1.04 0.15
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Going beyond this positive visual and refractive
outcome at 6 months, the next question to consider is
whether these improvements were stable over the long term
or, on the other hand, whether it would have been
appropriate to apply CXL in all cases to maintain positive
visual and refractive results. In the present study, 97 eyes
completed the 6- and 12-month follow-up visits; 71 eyes, the
6-, 12-, and 36-month visits; and 23 eyes completed the 6-,
12-, 36-, and 60-month follow-ups. Our results (Tables 2–4)
showed that, from the 6-month follow-up and thereafter,
visual and refractive ameliorations were stable. Despite this
stability, it is interesting to analyze how many eyes
experienced visual or refractive instability and, therefore,
a combined procedure (ICRS implantation + CXL) would
have been a better treatment approach. During the 12-month
follow-up period, only 1 eye (1.03%) lost 2 lines of CDVA,
and 3 eyes (5.1%) experienced refractive instability, but
without changes in CDVA. In turn, between the 12- and 36-
month visits, 3 eyes (4.2%) suffered visual instability, and 5
eyes (7.0%) showed refractive instability, but also without
changes in CDVA. Finally, between the follow-up at 36
months and the final visit at 5 years, no eyes showed visual
or refractive instability. These results imply that, for a high
percentage of cases, ICRS implantation alone provides
effective, safe, and stable visual and refractive improvement.
This outcome is in line with the results obtained by Or et al9
who, after a long-term evaluation of eyes treated with CXL
and of similar untreated eyes, concluded that, “there is no
urgency in treating paediatric patients with keratoconus
without progression. These patients should be closely
monitored for the earliest signs of progression, upon which
CXL should be promptly offered.”
In the present study, because the main aim was to
ameliorate visual quality, surgery was scheduled immediately
after keratoconus was diagnosed, without waiting to register
progression of the disease. Consequently, we cannot confirm
whether this procedure slowed down keratoconus progression.
However, the mean age of the patients included in this analysis
was 16.1 6 1.89 (range 10–18) and it is well established that,
at this age, the disease tends to progress more rapidly.3–5 What
we can state, however, is that Ferrara-type ICRS implantation
alone, using a femtosecond laser, is an apparently safe,
effective, and stable procedure for visual rehabilitation in
pediatric keratoconus. Furthermore, most eyes exhibited visual
and refractive stability over a 5-year follow-up period,
suggesting that in a few cases (around 6% in the 12-month
follow-up period and 11% between the 12- and 36-month
visits) a combined procedure (ICRS implantation and then
CXL) might have been a better treatment approach. In their
study, Or et al9 hypothesized that treating 1 eye with CXL
could make patients more reluctant to touch or rub their eyes,
eliminating or diminishing one of the main risk factors in
progression, namely eye rubbing,24 and could in turn help
stabilize keratoconus progression even in the untreated eye.
Similarly, undergoing surgery (ICRS implantation) could have
the same effect on patients with regard to eye rubbing.
Despite the encouraging results, we would like to note
some limitations of the study. The ICRS used in the current
study (Ferrara-type rings) are not available in some countries,
for example, in the United States. This was a retrospective
study and it was not possible to collect all the data from all
patients over the entire follow-up. Prospective studies includ-
ing more cases examined over a longer follow-up period are
required to validate the present results. Consequently, these
ICRS will be available in more countries.
In summary, present long-term results suggest that
Ferrara-type ICRS implantation is a safe and effective
procedure for visual restoration in pediatric patients with
keratoconus. This procedure reduces refractive error while
improving postsurgery UDVA and CDVA. In very few cases
was visual and/or refractive instability experienced, and
treatment with CXL might have been indicated.
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